Donald B. Borders

2.8k total citations · 1 hit paper
64 papers, 2.2k citations indexed

About

Donald B. Borders is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Donald B. Borders has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 32 papers in Pharmacology and 30 papers in Organic Chemistry. Recurrent topics in Donald B. Borders's work include Microbial Natural Products and Biosynthesis (27 papers), Cancer therapeutics and mechanisms (16 papers) and Chemical Synthesis and Analysis (12 papers). Donald B. Borders is often cited by papers focused on Microbial Natural Products and Biosynthesis (27 papers), Cancer therapeutics and mechanisms (16 papers) and Chemical Synthesis and Analysis (12 papers). Donald B. Borders collaborates with scholars based in United States, China and Russia. Donald B. Borders's co-authors include May D. Lee, Marshall M. Siegel, G. O. MORTON, T. S. DUNNE, George A. Ellestad, Conway C. Chang, Guy T. Carter, William J. McGahren, Terrence W. Doyle and David R. Williams and has published in prestigious journals such as Journal of the American Chemical Society, Accounts of Chemical Research and Analytical Chemistry.

In The Last Decade

Donald B. Borders

62 papers receiving 2.0k citations

Hit Papers

Calichemicins, a novel family of antitumor antibiotics. 2... 1987 2026 2000 2013 1987 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald B. Borders United States 23 1.4k 910 731 199 162 64 2.2k
G. O. MORTON United States 23 1.4k 1.0× 864 0.9× 525 0.7× 209 1.1× 203 1.3× 68 2.1k
William J. McGahren United States 20 1.0k 0.8× 762 0.8× 438 0.6× 152 0.8× 199 1.2× 41 1.8k
Isao Kawamoto Japan 21 698 0.5× 1.0k 1.1× 735 1.0× 151 0.8× 99 0.6× 101 1.8k
MAKI NISHIO Japan 27 822 0.6× 1.0k 1.1× 612 0.8× 213 1.1× 233 1.4× 83 2.2k
Sumio Umezawa Japan 25 2.0k 1.5× 1.7k 1.8× 984 1.3× 227 1.1× 173 1.1× 278 3.1k
HIROAKI OHKUMA Japan 19 1.4k 1.0× 747 0.8× 489 0.7× 137 0.7× 99 0.6× 27 1.9k
Mohindar S. Puar United States 27 960 0.7× 928 1.0× 919 1.3× 428 2.2× 87 0.5× 151 2.2k
Kiyoshi Isono Japan 34 2.0k 1.5× 2.1k 2.3× 1.1k 1.5× 331 1.7× 183 1.1× 164 3.6k
Mark Cushman United States 35 1.3k 1.0× 1.8k 2.0× 463 0.6× 69 0.3× 197 1.2× 120 3.5k
NOBORU OTAKE Japan 31 1.4k 1.0× 1.8k 2.0× 1.3k 1.8× 372 1.9× 255 1.6× 224 3.4k

Countries citing papers authored by Donald B. Borders

Since Specialization
Citations

This map shows the geographic impact of Donald B. Borders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald B. Borders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald B. Borders more than expected).

Fields of papers citing papers by Donald B. Borders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald B. Borders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald B. Borders. The network helps show where Donald B. Borders may publish in the future.

Co-authorship network of co-authors of Donald B. Borders

This figure shows the co-authorship network connecting the top 25 collaborators of Donald B. Borders. A scholar is included among the top collaborators of Donald B. Borders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald B. Borders. Donald B. Borders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schlingmann, Gerhard, Lisa Milne, Donald B. Borders, & Guy T. Carter. (1999). Strevertenes, antifungal pentaene macrolides produced by Streptoverticillcum LL-30F848. Tetrahedron. 55(19). 5977–5990. 16 indexed citations
2.
Borders, Donald B. & Terrence W. Doyle. (1995). Enediyne antibiotics as antitumor agents. M. Dekker eBooks. 105 indexed citations
3.
Schlingmann, Gerhard, Lisa Milne, Cedric J. Pearce, et al.. (1995). Isolation, Characterization and Structure of a New Allenic Polyine Antibiotic Produced by Fungus LL-07F275.. The Journal of Antibiotics. 48(5). 375–379. 14 indexed citations
4.
Northcote, Peter T., et al.. (1994). Glycothiohexide .ALPHA., a novel antibiotic produced by "Sebekia" sp., LL-14E605. III. Structural elucidation.. The Journal of Antibiotics. 47(8). 901–908. 26 indexed citations
5.
Carter, Guy T., Gerhard Schlingmann, Lisa Milne, et al.. (1994). Martinomycin, a new polyether antibiotic produced by Streptomyces salvialis. II. Isolation and structure determination.. The Journal of Antibiotics. 47(12). 1549–1553. 6 indexed citations
6.
Oliva, B, William M. Maiese, Michael Greenstein, Donald B. Borders, & Ian Chopra. (1993). Mode of action of the cyclic depsipeptide antibiotic LL-AO34β1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic. Journal of Antimicrobial Chemotherapy. 32(6). 817–830. 12 indexed citations
7.
Berova, Nina, et al.. (1993). ChemInform Abstract: Determination of the Absolute Stereochemistry of Nemadectins α2 and α. ChemInform. 24(1). 3 indexed citations
8.
Lee, May D., T. S. DUNNE, Conway C. Chang, et al.. (1992). Calicheamicins, a novel family of antitumor antibiotics. 4. Structure elucidation of calicheamicins .beta.1Br, .gamma.1Br, .alpha.2I, .alpha.3I, .beta.1I, .gamma.1I, and .delta.1I. Journal of the American Chemical Society. 114(3). 985–997. 105 indexed citations
9.
Chang, C. C., G. O. MORTON, John C. James, et al.. (1991). LL-AF283 antibiotics, cyclic biphenyl peptides.. The Journal of Antibiotics. 44(6). 674–677. 15 indexed citations
10.
Pearce, Cedric J., et al.. (1991). The effect of methylation inhibitors on citreamicin biosynthesis in Micromonospora citrea.. The Journal of Antibiotics. 44(11). 1247–1251. 9 indexed citations
11.
Carter, Guy T., et al.. (1990). Citreamicins, novel antibiotics from Micromonospora citrea. Isolation, characterization, and structure determination.. The Journal of Antibiotics. 43(5). 504–512. 41 indexed citations
12.
Tsou, Hwei‐Ru, et al.. (1989). Biosynthetic origin of the carbon skeleton and oxygen atoms of the LL-F28249.ALPHA., apoent antiparasitic macrolide.. The Journal of Antibiotics. 42(3). 398–406. 21 indexed citations
16.
Lee, May D., et al.. (1987). New antitumor antibiotic, LL-D05139.BETA.. Fermentation. isolation, structure determination and biological activities.. The Journal of Antibiotics. 40(12). 1657–1663. 14 indexed citations
17.
McGahren, William J., G. O. MORTON, Marshall M. Siegel, et al.. (1986). Chemistry of maduramicin. II Decarboxylation, abnormal ketalization and dehydration.. The Journal of Antibiotics. 39(11). 1541–1550. 2 indexed citations
18.
Carter, Guy T., et al.. (1985). Biosynthesis of chrysomycins A and B origin of the chromophore.. The Journal of Antibiotics. 38(2). 242–248. 24 indexed citations
19.
Hausmann, W., Donald B. Borders, & J. E. Lancaster. (1969). α, β-DIAMINOBUTYRIC ACID OBTAINED FROM ASPARTOCIN. The Journal of Antibiotics. 22(5). 207–210. 18 indexed citations
20.
Borders, Donald B., et al.. (1967). Partial structure of antibiotic LL-AC541. Tetrahedron Letters. 8(42). 4187–4192. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026